| Year |
Citation |
Score |
| 2025 |
Grol-Prokopczyk H, Huang R, Yu C, Chen YA, Kaur S, Limani M, Lin TH, Zajacova A, Zimmer Z, Cowan P, Fillingim RB, Gewandter JS, Gilron I, Hirsh AT, Macfarlane GJ, et al. Over 50 years of research on social disparities in pain and pain treatment: a scoping review of reviews. Pain. PMID 40553634 DOI: 10.1097/j.pain.0000000000003676 |
0.4 |
|
| 2025 |
Miller CJ, Bilker WB, DeLorey I, Argoff CE, Bell RL, Conroy A, Gewandter JS, Gilron I, Haythornthwaite JA, Katz NP, McWilliams T, Theken KN, Farrar JT. Minimum clinically important differences in acute pain: a patient-level re-analysis of randomized controlled analgesic trials submitted to the US Food and Drug Administration. Pain. PMID 40359379 DOI: 10.1097/j.pain.0000000000003645 |
0.453 |
|
| 2025 |
Geha P, Sulovari A, Freeman R, Gewandter JS. Dopaminergic modulation: revisiting a promising novel pathway for pharmacologic treatment of chronic pain. Pain. PMID 40288783 DOI: 10.1097/j.pain.0000000000003598 |
0.379 |
|
| 2024 |
Saab K, Gada U, Culakova E, Burnette B, Jorgensen C, Shah D, Morrow G, Mustian K, Sohn MB, Edwards RR, Freeman R, Langford DJ, McDermott MP, Gewandter JS. Personalized Outcomes in Neuropathic Pain: A Clinical Relevance and Assay Sensitivity Analysis from a Randomized Controlled Trial. Pain Medicine (Malden, Mass.). PMID 39365731 DOI: 10.1093/pm/pnae095 |
0.331 |
|
| 2024 |
Rangel M, Besharat S, Sohn MB, Foust M, Francar L, Jorgensen C, Mustian K, Morrow G, Culakova E, Jensen MP, Langford DJ, Gewandter JS. Mean of daily vs. single week recall-based pain quality assessments in neuropathic pain trials: Implications for assay sensitivity. The Journal of Pain. 104643. PMID 39067580 DOI: 10.1016/j.jpain.2024.104643 |
0.447 |
|
| 2024 |
Langford DJ, Mark RP, France FO, Nishtar M, Park M, Sharma S, Shklyar IC, Schnitzer TJ, Conaghan PG, Amtmann D, Reeve BB, Turk DC, Dworkin RH, Gewandter JS. Use of patient-reported global assessment measures in clinical trials of chronic pain treatments: ACTTION systematic review and considerations. Pain. PMID 38743561 DOI: 10.1097/j.pain.0000000000003270 |
0.417 |
|
| 2024 |
Hohenschurz-Schmidt D, Cherkin D, Rice ASC, Dworkin RH, Turk DC, McDermott MP, Bair MJ, DeBar LL, Edwards RR, Evans SR, Farrar JT, Kerns RD, Rowbotham MC, Wasan AD, Cowan P, ... ... Gewandter JS, et al. Methods for pragmatic randomized clinical trials of pain therapies: IMMPACT statement. Pain. PMID 38723171 DOI: 10.1097/j.pain.0000000000003249 |
0.417 |
|
| 2023 |
Haroutounian S, Holzer KJ, Kerns RD, Veasley C, Dworkin RH, Turk DC, Carman KL, Chambers CT, Cowan P, Edwards RR, Eisenach JC, Farrar JT, Ferguson M, Forsythe LP, Freeman R, ... Gewandter JS, et al. Patient engagement in designing, conducting, and disseminating clinical pain research: IMMPACT recommended considerations. Pain. PMID 38198239 DOI: 10.1097/j.pain.0000000000003121 |
0.318 |
|
| 2023 |
Gewandter JS, Culakova E, Davis JN, Gada U, Guido JJ, Bearden JD, Burnette B, Shah D, Morrow G, Mustian K, Sluka K, Mohile N. Wireless transcutaneous electric nerve stimulation (TENS) for chronic chemotherapy-induced peripheral neuropathy (CIPN): a proof-of-concept randomized clinical trial. The Journal of Pain. PMID 37993030 DOI: 10.1016/j.jpain.2023.11.014 |
0.386 |
|
| 2023 |
Langford DJ, Sharma S, McDermott MP, Beeram A, Besherat S, France FO, Mark R, Park M, Nishtar M, Turk DC, Dworkin RH, Gewandter JS. Covariate adjustment in chronic pain trials: An oft-missed opportunity. The Journal of Pain. PMID 37327942 DOI: 10.1016/j.jpain.2023.06.007 |
0.468 |
|
| 2023 |
Langford DJ, Baron R, Edwards RR, Gewandter JS, Gilron I, Griffin R, Kamerman PR, Katz NP, McDermott MP, Rice ASC, Turk DC, Vollert J, Dworkin RH. What should be the entry pain intensity criteria for chronic pain clinical trials? An IMMPACT update. Pain. PMID 37288944 DOI: 10.1097/j.pain.0000000000002930 |
0.466 |
|
| 2023 |
Gewandter JS, Edwards RR, Hill KP, Wasan AD, Hooker JE, Lape EC, Besharat S, Cowan P, Le Foll B, Ditre JW, Freeman R. Cannabinoid Therapy: Attitudes and Experiences of People With Chronic Pain. The Clinical Journal of Pain. PMID 36971412 DOI: 10.1097/AJP.0000000000001109 |
0.427 |
|
| 2023 |
Hohenschurz-Schmidt DJ, Cherkin D, Rice ASC, Dworkin RH, Turk DC, McDermott MP, Bair MJ, DeBar LL, Edwards RR, Farrar JT, Kerns RD, Markman JD, Rowbotham MC, Sherman KJ, Wasan AD, ... ... Gewandter JS, et al. Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statement. Pain. PMID 36943273 DOI: 10.1097/j.pain.0000000000002888 |
0.379 |
|
| 2022 |
Langford DJ, Lou R, Sheen S, Amtmann D, Colloca L, Edwards RR, Farrar JT, Katz NP, McDermott MP, Reeve BB, Wasan AD, Turk DC, Dworkin RH, Gewandter JS. Expectations for improvement: a neglected but potentially important covariate or moderator for chronic pain clinical trials. The Journal of Pain. PMID 36577461 DOI: 10.1016/j.jpain.2022.12.011 |
0.467 |
|
| 2022 |
Edwards RR, Schreiber KL, Dworkin RH, Turk DC, Baron R, Freeman R, Jensen TS, Latremoliere A, Markman JD, Rice ASC, Rowbotham M, Staud R, Tate S, Woolf CJ, Andrews NA, ... ... Gewandter JS, et al. Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations. The Journal of Pain. PMID 36198371 DOI: 10.1016/j.jpain.2022.08.010 |
0.466 |
|
| 2022 |
Langford DJ, Gewandter JS, Amtmann D, Reeve BB, Corneli A, McKenna K, Swezey T, McFatrich M, Jensen MP, Turk DC, Dworkin RH. Initial content validation and roadmap for a new patient-reported outcome measure of pain intensity. The Journal of Pain. PMID 35868594 DOI: 10.1016/j.jpain.2022.07.001 |
0.465 |
|
| 2022 |
Langford DJ, Gewandter JS, Amtmann D, Reeve BB, Hertz S, Loeser JD, Veasley C, Turk DC, Dworkin RH. Patient-Reported Chronic Pain Intensity: More Than Meets the Eye. The Patient. 15: 383-387. PMID 35676465 DOI: 10.1007/s40271-022-00585-9 |
0.341 |
|
| 2022 |
Gewandter JS, Sohn MB, De Guzman R, Frazer ME, Chiodo V, Sharma S, Geha P, Markman JD. Predicting treatment response with sensory phenotyping in post-traumatic neuropathic pain. Pain Medicine (Malden, Mass.). PMID 35312012 DOI: 10.1093/pm/pnac045 |
0.449 |
|
| 2022 |
Holzer KJ, Veasley C, Kerns RD, Edwards RR, Gewandter JS, Langford DJ, Yaeger LH, McNicol E, Ferguson M, Turk DC, Dworkin RH, Haroutounian S. Partnering with patients in clinical trials of pain treatments: a narrative review. Pain. PMID 35297799 DOI: 10.1097/j.pain.0000000000002600 |
0.416 |
|
| 2022 |
Zhang Z, Gewandter JS, Geha P. Brain Imaging Biomarkers for Chronic Pain. Frontiers in Neurology. 12: 734821. PMID 35046881 DOI: 10.3389/fneur.2021.734821 |
0.369 |
|
| 2021 |
Kleykamp BA, Dworkin RH, Turk DC, Bhagwagar Z, Cowan P, Eccleston C, Ellenberg SS, Evans SR, Gewandter JS, Goli V, Farrar JT, Freeman RL, Garrison LP, Iyengar S, Jadad AR, et al. Benefit-risk assessment and reporting in clinical trials of chronic pain treatments: IMMPACT Recommendations. Pain. PMID 34510135 DOI: 10.1097/j.pain.0000000000002475 |
0.397 |
|
| 2021 |
Philip A, Williams M, Davis J, Beeram A, Feng C, Poli J, Vangellow A, Gewandter J. Evaluating predictors of pain reduction after genicular nerve radiofrequency ablation for chronic knee pain. Pain Management. PMID 34102879 DOI: 10.2217/pmt-2021-0014 |
0.411 |
|
| 2021 |
Gewandter JS, Dworkin RH, Turk DC, Farrar JT, Fillingim RB, Gilron I, Markman JD, Oaklander AL, Polydefkis MJ, Raja SN, Robinson JP, Woolf CJ, Ziegler D, Ashburn MA, Burke LB, et al. Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations. Pain Reports. 6: e895. PMID 33981929 DOI: 10.1097/PR9.0000000000000895 |
0.461 |
|
| 2021 |
Gewandter JS, Smith SM, Dworkin RH, Turk DC, Gan TJ, Gilron I, Hertz S, Katz NP, Markman JD, Raja SN, Rowbotham MC, Stacey BR, Strain EC, Ward DS, Farrar JT, et al. Research approaches for evaluating opioid sparing in clinical trials of acute and chronic pain treatments: IMMPACT recommendations. Pain. PMID 33863862 DOI: 10.1097/j.pain.0000000000002283 |
0.33 |
|
| 2021 |
Katz N, Dworkin RH, North R, Thomson S, Eldabe S, Hayek SM, Kopell BH, Markman J, Rezai A, Taylor RS, Turk DC, Buchser E, Fields H, Fiore G, Ferguson M, ... Gewandter J, et al. Research design considerations for randomized controlled trials of spinal cord stimulation for pain: IMMPACT/ION/INS recommendations. Pain. PMID 33470748 DOI: 10.1097/j.pain.0000000000002204 |
0.349 |
|
| 2021 |
Gewandter JS, McDermott MP, Evans S, Katz NP, Markman JD, Simon LS, Turk DC, Dworkin RH. Composite outcomes for pain trials: considerations for design and interpretation. Pain. PMID 33449513 DOI: 10.1097/j.pain.0000000000002188 |
0.378 |
|
| 2020 |
McNicol E, Ferguson M, Bungay K, Rowe EL, Eldabe S, Gewandter JS, Hayek SM, Katz N, Kopell BH, Markman J, Rezai A, Taylor RS, Turk DC, Dworkin RH, North RB, et al. Systematic Review of Research Methods and Reporting Quality of Randomized Clinical Trials of Spinal Cord Stimulation for Pain. The Journal of Pain : Official Journal of the American Pain Society. PMID 32574787 DOI: 10.1016/j.jpain.2020.05.001 |
0.367 |
|
| 2020 |
Cai X, Gewandter JS, He H, Turk DC, Dworkin RH, McDermott MP. Estimands and missing data in clinical trials of chronic pain treatments: advances in design and analysis. Pain. PMID 32453131 DOI: 10.1097/J.Pain.0000000000001937 |
0.428 |
|
| 2020 |
Markman JD, Gewandter JS, Frazer ME. Comparison of a Pain Tolerability Question With the Numeric Rating Scale for Assessment of Self-reported Chronic Pain. Jama Network Open. 3: e203155. PMID 32310281 DOI: 10.1001/jamanetworkopen.2020.3155 |
0.383 |
|
| 2019 |
Gewandter JS, Dworkin RH, Turk DC, Devine EG, Hewitt D, Jensen MP, Katz NP, Kirkwood AA, Malamut R, Markman JD, Vrijens B, Burke L, Campbell JN, Carr DB, Conaghan PG, et al. Improving study conduct and data quality in clinical trials of chronic pain treatments: IMMPACT recommendations. The Journal of Pain : Official Journal of the American Pain Society. PMID 31843583 DOI: 10.1016/J.Jpain.2019.12.003 |
0.362 |
|
| 2019 |
Park SB, Alberti P, Kolb NA, Gewandter JS, Schenone A, Argyriou AA. Overview and critical revision of clinical assessment tools in chemotherapy-induced peripheral neurotoxicity. Journal of the Peripheral Nervous System : Jpns. 24: S13-S25. PMID 31647154 DOI: 10.1111/jns.12333 |
0.335 |
|
| 2019 |
Mbowe OB, Gewandter JS, Turk DC, Dworkin RH, McDermott MP. Are there really only two kinds of people in the world? Evaluating the distribution of change from baseline in pain clinical trials. Pain. PMID 31569143 DOI: 10.1097/J.Pain.0000000000001708 |
0.462 |
|
| 2019 |
Gewandter JS, McDermott MP, Mbowe O, Edwards RR, Katz NP, Turk DC, Dworkin RH. Navigating trials of personalized pain treatments: we're going to need a bigger boat. Pain. PMID 30694930 DOI: 10.1097/J.Pain.0000000000001504 |
0.439 |
|
| 2019 |
Gewandter JS, Frazer ME, Cai X, Chiodo VF, Rast SA, Dugan M, Carter HA, Rahmani R, Stone JJ, Markman JD. Extended-release gabapentin for failed back surgery syndrome: results from a randomized double-blind cross-over study. Pain. PMID 30624344 DOI: 10.1097/J.Pain.0000000000001478 |
0.425 |
|
| 2019 |
Gewandter JS, Eisenach JC, Gross RA, Jensen MP, Keefe FJ, Lee DA, Turk DC. Checklist for the preparation and review of pain clinical trial publications: a pain-specific supplement to CONSORT. Pain Reports. 4: e621. PMID 28989992 DOI: 10.1097/PR9.0000000000000621 |
0.411 |
|
| 2018 |
Connolly MR, Chaudari JY, Yang X, Ward N, Kitt RA, Herrmann RS, Krane EJ, LeBel AA, Smith SM, Walco GA, Weisman SJ, Turk DC, Dworkin RH, Gewandter JS. Design and reporting characteristics of clinical trials of select chronic and recurrent pediatric pain conditions: An ACTTION systematic review. The Journal of Pain : Official Journal of the American Pain Society. PMID 30219729 DOI: 10.1016/J.Jpain.2018.08.007 |
0.46 |
|
| 2018 |
Gewandter JS, Chaudari J, Ibegbu C, Kitt R, Serventi J, Burke J, Culakova E, Kolb N, Sluka KA, Tejani MA, Mohile NA. Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 30151681 DOI: 10.1007/S00520-018-4424-6 |
0.32 |
|
| 2018 |
Patel KV, Allen R, Burke L, Farrar JT, Gewandter JS, Gilron I, Katz NP, Markman JD, Marshall SF, Resnick M, Rice ASC, Rowbotham MC, Smith SM, Vanhove GF, Wasan AD, et al. Evaluation of composite responder outcomes of pain intensity and physical function in neuropathic pain clinical trials: an ACTTION individual patient data analysis. Pain. PMID 30001225 DOI: 10.1097/J.Pain.0000000000001324 |
0.453 |
|
| 2018 |
Markman JD, Baron R, Gewandter JS. Why are there no drugs indicated for sciatica, the most common chronic neuropathic syndrome of all? Drug Discovery Today. PMID 29894812 DOI: 10.1016/j.drudis.2018.06.004 |
0.425 |
|
| 2018 |
Gewandter JS, Chaudari J, Iwan KB, Kitt R, As-Sanie S, Bachmann G, Clemens Q, Lai HH, Tu F, Verne GN, Vincent K, Wesselmann U, Zhou Q, Turk DC, Dworkin RH, et al. Research Design Characteristics of Published Pharmacologic Randomized Clinical Trials for Irritable Bowel Syndrome and Chronic Pelvic Pain Conditions: an Acttion Systemic Review. The Journal of Pain : Official Journal of the American Pain Society. PMID 29412183 DOI: 10.1016/J.Jpain.2018.01.007 |
0.476 |
|
| 2018 |
Smith S, Gewandter J, Chaudari J, McDermott M, Gilron I, Kitt R, Koch J, Majeed Z, Park M, Turk D, Dworkin R. Interpretations of statistically non-significant comparisons between active pain treatments: An ACTTION systematic review The Journal of Pain. 19: S60. DOI: 10.1016/J.Jpain.2017.12.155 |
0.466 |
|
| 2018 |
Gewandter J, Northwood S, Frazier M, DelVecchio J, Judge S, Swanger C, Markman J. A prospective study of patient satisfaction with communication regarding chronic pain in the primary care setting: Do opioid prescriptions matter? The Journal of Pain. 19. DOI: 10.1016/J.Jpain.2017.12.135 |
0.38 |
|
| 2017 |
Kent ML, Tighe PJ, Belfer I, Brennan TJ, Bruehl S, Brummett CM, Buckenmaier CC, Buvanendran A, Cohen RI, Desjardins P, Edwards D, Fillingim R, Gewandter J, Gordon DB, Hurley RW, et al. The ACTTION-APS-AAPM Pain Taxonomy (AAAPT) Multidimensional Approach to Classifying Acute Pain Conditions. The Journal of Pain : Official Journal of the American Pain Society. 18: 479-489. PMID 28495013 DOI: 10.1016/J.Jpain.2017.02.421 |
0.475 |
|
| 2017 |
Kent ML, Tighe PJ, Belfer I, Brennan TJ, Bruehl S, Brummett CM, Buckenmaier CC, Buvanendran A, Cohen RI, Desjardins P, Edwards D, Fillingim R, Gewandter J, Gordon DB, Hurley RW, et al. The ACTTION-APS-AAPM Pain Taxonomy (AAAPT) Multidimensional Approach to Classifying Acute Pain Conditions. Pain Medicine (Malden, Mass.). PMID 28482098 DOI: 10.1093/Pm/Pnx019 |
0.474 |
|
| 2017 |
Rothstein D, Kitt RA, Smith SM, Abdi S, Engle MP, McDermott MP, Raja SN, Turk DC, Dworkin RH, Gewandter JS. Reporting of Design Features and Analysis Details in Randomized Clinical Trials of Procedural Treatments for Cancer Pain: An ACTTION Systematic Review. Regional Anesthesia and Pain Medicine. PMID 28085789 DOI: 10.1097/Aap.0000000000000553 |
0.402 |
|
| 2017 |
Gewandter J, Kitt R, Freeman R, McDermott M, Mohile N, Mohile S, Smith A, Turk D, Dworkin R. (470) Research design characteristics and clarity of reporting in trials of chemotherapy-induced peripheral neuropathy treatments initiated during chemotherapy: An ACTTION systematic review The Journal of Pain. 18: S91. DOI: 10.1016/J.Jpain.2017.02.320 |
0.351 |
|
| 2017 |
Markman J, Frazer M, Northwood S, Rullan V, Pittman C, Gewandter J. 465) Preliminary Results of the MIP (Maximal Intensity Pain) Retrospective Cross Sectional Study The Journal of Pain. 18. DOI: 10.1016/J.Jpain.2017.02.315 |
0.401 |
|
| 2016 |
Smith S, Gewandter J, Kitt R, Cowan P, Markman J, Vaughan J, Sadosky A, Tive L, Turk D, Dworkin R. (202) Preferences for pain clinical trial characteristics: an ACTTION adaptive choice-based conjoint survey study. The Journal of Pain : Official Journal of the American Pain Society. 17: S26. PMID 28162429 DOI: 10.1016/J.Jpain.2016.01.105 |
0.473 |
|
| 2016 |
Gewandter J, McKeown A, McDermott M, Hoang K, Kataryzyna I, Kralovic S, Rothstein D, Gilron I, Katz N, Senn S, Smith S, Turk D, Dworkin R. (149) Reporting of cross-over clinical trials of analgesic treatments for neuropathic and musculoskeletal pain: ACTTION systematic review and recommendations. The Journal of Pain : Official Journal of the American Pain Society. 17: S13. PMID 28162374 DOI: 10.1016/J.Jpain.2016.01.052 |
0.516 |
|
| 2016 |
Gewandter JS, Dworkin RH, Finnerup NB, Mohile NA. Painful chemotherapy-induced peripheral neuropathy: lack of treatment efficacy or the wrong clinical trial methodology? Pain. PMID 27564867 DOI: 10.1097/j.pain.0000000000000653 |
0.462 |
|
| 2016 |
Smith SM, Gewandter JS, Kitt RA, Markman JD, Vaughan JA, Cowan P, Kopecky EA, Malamut R, Sadosky A, Tive L, Turk DC, Dworkin RH. Participant preferences for pharmacologic chronic pain treatment trial characteristics: an ACTTION adaptive choice-based conjoint study. The Journal of Pain : Official Journal of the American Pain Society. PMID 27555429 DOI: 10.1016/J.Jpain.2016.07.008 |
0.406 |
|
| 2016 |
Gewandter JS, McDermott MP, McKeown A, Hoang K, Iwan K, Kralovic S, Rothstein D, Gilron I, Katz NP, Raja SN, Senn S, Smith SM, Turk DC, Dworkin RH. Reporting of cross-over clinical trials of analgesic treatments for chronic pain: ACTTION systematic review and recommendations. Pain. PMID 27437786 DOI: 10.1097/J.Pain.0000000000000673 |
0.332 |
|
| 2016 |
Edwards RR, Dworkin RH, Turk DC, Angst MS, Dionne R, Freeman R, Hansson P, Haroutounian S, Arendt-Nielsen L, Attal N, Baron R, Brell J, Bujanover S, Burke LB, Carr D, ... ... Gewandter JS, et al. Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations. Pain. PMID 27152687 DOI: 10.1097/J.Pain.0000000000000602 |
0.399 |
|
| 2016 |
Smith SM, Amtmann D, Askew RL, Gewandter JS, Hunsinger M, Jensen MP, McDermott MP, Patel KV, Williams M, Bacci ED, Burke LB, Chambers CT, Cooper SA, Cowan P, Desjardins P, et al. Pain intensity rating training: results from an exploratory study of the ACTTION PROTECCT system©. Pain. PMID 27058680 DOI: 10.1097/J.Pain.0000000000000502 |
0.388 |
|
| 2016 |
Taylor AM, Phillips K, Patel KV, Turk DC, Dworkin RH, Beaton D, Clauw DJ, Gignac MA, Markman JD, Williams DA, Bujanover S, Burke LB, Carr DB, Choy EH, Conaghan PG, ... ... Gewandter J, et al. Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations. Pain. 157: 1836-50. PMID 27058676 DOI: 10.1097/J.Pain.0000000000000577 |
0.468 |
|
| 2015 |
Andrews NA, Latrémolière A, Basbaum AI, Mogil JS, Porreca F, Rice AS, Woolf CJ, Currie GL, Dworkin RH, Eisenach JC, Evans S, Gewandter JS, Gover TD, Handwerker H, Huang W, et al. Ensuring transparency and minimization of methodologic bias in preclinical pain research: Pprecise considerations. Pain. PMID 26683237 DOI: 10.1097/J.Pain.0000000000000458 |
0.399 |
|
| 2015 |
Dworkin JD, McKeown A, Farrar JT, Gilron I, Hunsinger M, Kerns RD, McDermott MP, Rappaport BA, Turk DC, Dworkin RH, Gewandter JS. Deficiencies in reporting of statistical methodology in recent randomized trials of non-pharmacologic pain treatments: ACTTION systematic review. Journal of Clinical Epidemiology. PMID 26597977 DOI: 10.1016/J.Jclinepi.2015.10.019 |
0.41 |
|
| 2015 |
Markman JD, Gewandter JS, Frazer ME, Pittman C, Cai X, Patel KV, Jahromi BS, Dworkin RH, Burke LB, Farrar JT. Evaluation of outcome measures for neurogenic claudication: A patient-centered approach. Neurology. PMID 26354988 DOI: 10.1212/Wnl.0000000000002000 |
0.354 |
|
| 2015 |
Gewandter JS, Dworkin RH, Turk DC, Farrar JT, Fillingim RB, Gilron I, Markman JD, Oaklander AL, Polydefkis MJ, Raja SN, Robinson JP, Woolf CJ, Ziegler D, Ashburn MA, Burke LB, et al. Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations. Pain. 156: 1184-97. PMID 25887465 DOI: 10.1097/J.Pain.0000000000000191 |
0.461 |
|
| 2015 |
Gewandter JS, Smith SM, McKeown A, Edwards K, Narula A, Pawlowski JR, Rothstein D, Desjardins PJ, Dworkin SF, Gross RA, Ohrbach R, Rappaport BA, Sessle BJ, Turk DC, Dworkin RH. Reporting of adverse events and statistical details of efficacy estimates in randomized clinical trials of pain in temporomandibular disorders: Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks systematic review. Journal of the American Dental Association (1939). 146: 246-54.e6. PMID 25819656 DOI: 10.1016/J.Adaj.2014.12.023 |
0.336 |
|
| 2015 |
McKeown A, Gewandter JS, McDermott MP, Pawlowski JR, Poli JJ, Rothstein D, Farrar JT, Gilron I, Katz NP, Lin AH, Rappaport BA, Rowbotham MC, Turk DC, Dworkin RH, Smith SM. Reporting of sample size calculations in analgesic clinical trials: ACTTION systematic review. The Journal of Pain : Official Journal of the American Pain Society. 16: 199-206.e1-7. PMID 25481494 DOI: 10.1016/J.Jpain.2014.11.010 |
0.367 |
|
| 2015 |
Dworkin RH, Burke LB, Gewandter JS, Smith SM. Reliability is Necessary but Far From Sufficient: How Might the Validity of Pain Ratings be Improved? The Clinical Journal of Pain. 31: 599-602. PMID 25370141 DOI: 10.1097/Ajp.0000000000000175 |
0.353 |
|
| 2014 |
Gewandter JS, McDermott MP, McKeown A, Smith SM, Pawlowski JR, Poli JJ, Rothstein D, Williams MR, Bujanover S, Farrar JT, Gilron I, Katz NP, Rowbotham MC, Turk DC, Dworkin RH. Reporting of intention-to-treat analyses in recent analgesic clinical trials: ACTTION systematic review and recommendations. Pain. 155: 2714-9. PMID 25284072 DOI: 10.1016/J.Pain.2014.09.039 |
0.439 |
|
| 2014 |
Gewandter JS, McDermott MP, McKeown A, Smith SM, Williams MR, Hunsinger M, Farrar J, Turk DC, Dworkin RH. Reporting of missing data and methods used to accommodate them in recent analgesic clinical trials: ACTTION systematic review and recommendations. Pain. 155: 1871-7. PMID 24993384 DOI: 10.1016/J.Pain.2014.06.018 |
0.388 |
|
| 2014 |
Gewandter JS, Dworkin RH, Turk DC, McDermott MP, Baron R, Gastonguay MR, Gilron I, Katz NP, Mehta C, Raja SN, Senn S, Taylor C, Cowan P, Desjardins P, Dimitrova R, et al. Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations. Pain. 155: 1683-95. PMID 24865794 DOI: 10.1016/J.Pain.2014.05.025 |
0.338 |
|
| 2014 |
Fillingim RB, Bruehl S, Dworkin RH, Dworkin SF, Loeser JD, Turk DC, Widerstrom-Noga E, Arnold L, Bennett R, Edwards RR, Freeman R, Gewandter J, Hertz S, Hochberg M, Krane E, et al. The ACTTION-American Pain Society Pain Taxonomy (AAPT): an evidence-based and multidimensional approach to classifying chronic pain conditions. The Journal of Pain : Official Journal of the American Pain Society. 15: 241-9. PMID 24581634 DOI: 10.1016/J.Jpain.2014.01.004 |
0.491 |
|
| 2014 |
Gewandter JS, Smith SM, McKeown A, Burke LB, Hertz SH, Hunsinger M, Katz NP, Lin AH, McDermott MP, Rappaport BA, Williams MR, Turk DC, Dworkin RH. Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION systematic review and recommendations. Pain. 155: 461-6. PMID 24275257 DOI: 10.1016/J.Pain.2013.11.009 |
0.428 |
|
| 2014 |
Gewandter J, McDermott M, McKeown A, Smith S, Farrar J, Hertz S, Hinsinger M, Lin A, Rappaport B, Williams M, Turk D, Dworkin R. (263) Methods used to manage missing data in recent analgesic clinical trials: ACTTION systematic review and recommendations The Journal of Pain. 15: S41. DOI: 10.1016/J.Jpain.2014.01.171 |
0.32 |
|
| 2012 |
Gewandter J, Heckler C, Kirshner J, Roscoe J, Morrow G. Naproxen reduces chemotherapy and pegfilgrastim-induced sleep disturbance possibly mediated through reduced bone pain The Journal of Pain. 13: S65. DOI: 10.1016/J.Jpain.2012.01.271 |
0.351 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2019 |
Gewandter JS, McDermott MP, He H, Gao S, Cai X, Farrar JT, Katz NP, Markman JD, Senn S, Turk DC, Dworkin RH. Demonstrating heterogeneity of treatment effects among patients: an overlooked but important step toward precision medicine. Clinical Pharmacology and Therapeutics. PMID 30661240 DOI: 10.1002/Cpt.1372 |
0.293 |
|
| 2015 |
Markman JD, Barbosa WA, Gewandter JS, Frazer M, Rast S, Dugan M, Nandigam K, Villareal A, Kwong TC. Interpretation of urine drug testing results in patients using transdermal buprenorphine preparations for the treatment of chronic noncancer pain. Pain Medicine (Malden, Mass.). 16: 1132-6. PMID 25800409 DOI: 10.1111/pme.12740 |
0.291 |
|
| 2024 |
Williams MR, Philip A, Sheen S, Aujla S, Feng C, Gao S, Kralovic S, Poli J, Ortiz T, Stefanos T, Pennella-Vaughan J, Gewandter JS. Non-inferiority study assessing the utility of postcervical and lumbar radiofrequency ablation steroid use. Regional Anesthesia and Pain Medicine. PMID 39097327 DOI: 10.1136/rapm-2024-105501 |
0.288 |
|
| 2015 |
Kiluk BD, Carroll KM, Duhig A, Falk DE, Kampman K, Lai S, Litten RZ, McCann DJ, Montoya ID, Preston KL, Skolnick P, Weisner C, Woody G, Chandler R, Detke MJ, ... ... Gewandter J, et al. Measures of outcome for stimulant trials: ACTTION recommendations and research agenda. Drug and Alcohol Dependence. PMID 26652899 DOI: 10.1016/J.Drugalcdep.2015.11.004 |
0.283 |
|
| 2017 |
Gewandter JS, Freeman R, Kitt RA, Cavaletti G, Gauthier LR, McDermott MP, Mohile NA, Mohlie SG, Smith AG, Tejani MA, Turk DC, Dworkin RH. Chemotherapy-induced peripheral neuropathy clinical trials: Review and recommendations. Neurology. PMID 28747442 DOI: 10.1212/Wnl.0000000000004272 |
0.282 |
|
| 2015 |
Gewandter JS, McKeown A, McDermott MP, Dworkin JD, Smith SM, Gross RA, Hunsinger M, Lin AH, Rappaport BA, Rice AS, Rowbotham MC, Williams MR, Turk DC, Dworkin RH. Data interpretation in analgesic clinical trials with statistically nonsignificant primary analyses: an ACTTION systematic review. The Journal of Pain : Official Journal of the American Pain Society. 16: 3-10. PMID 25451621 DOI: 10.1016/J.Jpain.2014.10.003 |
0.281 |
|
| 2023 |
Nishtar M, Mark R, Langford DJ, McDermott MP, Markman JD, Evans SR, France FO, Park M, Sharma S, Turk DC, Dworkin RH, Gewandter JS. Evaluating the balance of benefits and harms in chronic pain clinical trials: prioritizing individual participants over individual outcomes. Regional Anesthesia and Pain Medicine. PMID 37963675 DOI: 10.1136/rapm-2023-104809 |
0.279 |
|
| 2019 |
Culakova E, Mohamed M, Flannery M, Patil A, Obrecht S, Xu H, Carpenter K, Jonnalagadda S, Plumb S, Kleckner A, Loh MKP, Gewandter J, Kleckner I, Mohile S. Patient-Reported Numbness And Tingling Augments Common Terminology Criteria For Adverse Events (Ctcae) To Detect Chemotherapy-Induced Peripheral Neuropathy (Cipn) In Older Adults With Advanced Cancer Undergoing Systemic Treatment Journal of Geriatric Oncology. 10. DOI: 10.1016/S1879-4068(19)31231-7 |
0.275 |
|
| 2013 |
Gewandter JS, Walker J, Heckler CE, Morrow GR, Ryan JL. Characterization of skin reactions and pain reported by patients receiving radiation therapy for cancer at different sites. The Journal of Supportive Oncology. 11: 183-9. PMID 24645338 DOI: 10.12788/J.Suponc.0009 |
0.273 |
|
| 2022 |
Knoerl R, Berry D, Meyerhardt JA, Reyes K, Salehi E, Thornton K, Gewandter JS. Identifying participants' preferences for modifiable chemotherapy-induced peripheral neuropathy prevention clinical trial factors: an adaptive choice-based conjoint analysis. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 30: 9963-9973. PMID 36355216 DOI: 10.1007/s00520-022-07447-y |
0.268 |
|
| 2025 |
Conroy A, Bilker WB, Miller CJ, Argoff CE, Bell R, Haythornthwaite J, Gewandter JS, Gilron I, Theken KN, Farrar JT. Predictors of successful initiation of buprenorphine in enriched enrollment randomized withdrawal clinical trials in both opioid experienced and naïve participants: a participant-level meta-analysis. Pain Reports. 10: e1281. PMID 40486924 DOI: 10.1097/PR9.0000000000001281 |
0.267 |
|
| 2024 |
Kleckner IR, Manuweera T, Lin PJ, Chung KH, Kleckner AS, Gewandter JS, Culakova E, Tivarus ME, Dunne RF, Loh KP, Mohile NA, Kesler SR, Mustian KM. Pilot trial testing the effects of exercise on chemotherapy-induced peripheral neurotoxicity (CIPN) and the interoceptive brain system. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 32: 677. PMID 39304604 DOI: 10.1007/s00520-024-08855-y |
0.261 |
|
| 2019 |
Ryan Wolf J, Gewandter JS, Bautista J, Heckler CE, Strasser J, Dyk P, Anderson T, Gross H, Speer T, Dolohanty L, Bylund K, Pentland AP, Morrow GR. Utility of topical agents for radiation dermatitis and pain: a randomized clinical trial. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 31758326 DOI: 10.1007/S00520-019-05166-5 |
0.258 |
|
| 2018 |
Gewandter JS, Brell J, Cavaletti G, Dougherty PM, Evans S, Howie L, McDermott MP, O'Mara A, Smith AG, Dastros-Pitei D, Gauthier LR, Haroutounian S, Jarpe M, Katz NP, Loprinzi C, et al. Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations. Neurology. PMID 30054438 DOI: 10.1212/Wnl.0000000000006083 |
0.252 |
|
| 2024 |
Sheen S, Markman J, Sohn M, Bhatia A, Haddas R, Geha P, Gewandter J. Multidevice spinal cord stimulation trials: shared decision making in the era of multiple neuromodulation paradigms. Pain Management. 1-8. PMID 39324559 DOI: 10.1080/17581869.2024.2401767 |
0.246 |
|
| 2017 |
Gewandter J, Chaudari J, Kitt R, Ibegbu C, Serventi J, Burke J, Mohile N. (461) Wearable TENs band for chemotherapy-induced peripheral neuropathy (CIPN): a feasibility study The Journal of Pain. 18. DOI: 10.1016/J.Jpain.2017.02.311 |
0.242 |
|
| 2015 |
Peppone LJ, Janelsins MC, Kamen C, Mohile SG, Sprod LK, Gewandter JS, Kirshner JJ, Gaur R, Ruzich J, Esparaz BT, Mustian KM. The effect of YOCAS©® yoga for musculoskeletal symptoms among breast cancer survivors on hormonal therapy. Breast Cancer Research and Treatment. 150: 597-604. PMID 25814054 DOI: 10.1007/S10549-015-3351-1 |
0.241 |
|
| 2017 |
Gewandter JS, McDermott MP, Kitt RA, Chaudari J, Koch JG, Evans SR, Gross RA, Markman JD, Turk DC, Dworkin RH. Interpretation of CIs in clinical trials with non-significant results: systematic review and recommendations. Bmj Open. 7: e017288. PMID 28720618 DOI: 10.1136/Bmjopen-2017-017288 |
0.235 |
|
| 2012 |
Chandwani KD, Ryan JL, Peppone LJ, Janelsins MM, Sprod LK, Devine K, Trevino L, Gewandter J, Morrow GR, Mustian KM. Cancer-related stress and complementary and alternative medicine: a review. Evidence-Based Complementary and Alternative Medicine : Ecam. 2012: 979213. PMID 22844341 DOI: 10.1155/2012/979213 |
0.234 |
|
| 2022 |
Knoerl R, Berry DL, Meyerhardt J, Reyes K, Salehi E, Gewandter JS. Exploring Patients' Understanding of Chemotherapy-Induced Peripheral Neuropathy. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. PMID 35927535 DOI: 10.1007/s13187-022-02206-3 |
0.221 |
|
| 2021 |
Lee JJ, Price JC, Gewandter J, Kleykamp BA, Biagas KV, Naim MY, Ward D, Dworkin RH, Sun LS. Design and reporting characteristics of clinical trials investigating sedation practices in the paediatric intensive care unit: a scoping review by SCEPTER (Sedation Consortium on Endpoints and Procedures for Treatment, Education and Research). Bmj Open. 11: e053519. PMID 34649849 DOI: 10.1136/bmjopen-2021-053519 |
0.221 |
|
| 2014 |
Gewandter JS, Mohile SG, Heckler CE, Ryan JL, Kirshner JJ, Flynn PJ, Hopkins JO, Morrow GR. A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 22: 1807-14. PMID 24531792 DOI: 10.1007/S00520-014-2158-7 |
0.217 |
|
| 2024 |
Knoerl R, Sohn MB, Spath K, Burnette B, Francar L, Mustian KM, Shah D, Gauthier L, Gewandter JS. Exploring the reliability and validity of clinically-relevant outcome measures for chemotherapy-induced peripheral neuropathy. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 32: 675. PMID 39297964 DOI: 10.1007/s00520-024-08878-5 |
0.212 |
|
| 2017 |
Gewandter JS, Kitt RA, Hunsinger MR, Poku J, Lozano J, Chaudari J, Evans S, Gross RA, McDermott MP, Rowbotham MC, Turk DC, Dworkin RH. Reporting of data monitoring boards in publications of randomized clinical trials is often deficient: An ACTTION systematic review. Journal of Clinical Epidemiology. PMID 28126598 DOI: 10.1016/J.Jclinepi.2016.12.018 |
0.211 |
|
| 2024 |
Knoerl R, Sohn MB, Foust M, Francar L, O'Rourke MA, Morrow GM, Mustian KM, Gauthier L, Gewandter JS. Exploring Analgesic Use Patterns Among Cancer Survivors With Chronic Chemotherapy-Induced Peripheral Neuropathy. Oncology Nursing Forum. 51: 445-450. PMID 39162787 DOI: 10.1188/24.ONF.445-450 |
0.208 |
|
| 2017 |
Kleckner IR, Kamen C, Gewandter JS, Mohile NA, Heckler CE, Culakova E, Fung C, Janelsins MC, Asare M, Lin PJ, Reddy PS, Giguere J, Berenberg J, Kesler SR, Mustian KM. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 29243164 DOI: 10.1007/S00520-017-4013-0 |
0.205 |
|
| 2011 |
Janelsins MC, Mustian KM, Peppone LJ, Sprod LK, Shayne M, Mohile S, Chandwani K, Gewandter JS, Morrow GR. Interventions to Alleviate Symptoms Related to Breast Cancer Treatments and Areas of Needed Research. Journal of Cancer Science & Therapy. PMID 22855701 DOI: 10.4172/1948-5956.S2-001 |
0.202 |
|
| 2019 |
Gewandter JS, Gibbons CH, Campagnolo M, Lee J, Chaudari J, Ward N, Burke L, Cavaletti G, Herrmann DN, McArthur JC, Russell JW, Smith AG, Smith SM, Turk DC, Dworkin RH, et al. Clinician-rated measures for distal symmetrical axonal polyneuropathy: ACTTION systematic review. Neurology. PMID 31320471 DOI: 10.1212/Wnl.0000000000007974 |
0.188 |
|
| 2022 |
Bérubé-Mercier P, Tapp D, Cimon MÈ, Li T, Park SB, Bouhêlier É, McGarragle K, Robichaud LA, Gewandter JS, Bouchard M, Gauthier LR. Evaluation of the psychometric properties of patient-reported and clinician-reported outcome measures of chemotherapy-induced peripheral neuropathy: a COSMIN systematic review protocol. Bmj Open. 12: e057950. PMID 35387828 DOI: 10.1136/bmjopen-2021-057950 |
0.183 |
|
| 2019 |
Gewandter JS, Kleckner AS, Marshall JH, Brown JS, Curtis LH, Bautista J, Dworkin RH, Kleckner IR, Kolb N, Mohile SG, Mustian KM. Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 31494735 DOI: 10.1007/S00520-019-05063-X |
0.182 |
|
| 2004 |
Braslau R, Tsimelzon A, Gewandter J. Novel methodology for the synthesis of N-alkoxyamines. Organic Letters. 6: 2233-5. PMID 15200328 DOI: 10.1021/Ol049271V |
0.18 |
|
| 2024 |
Kleckner IR, Manuweera T, Lin PJ, Chung KH, Kleckner AS, Gewandter JS, Culakova E, Tivarus ME, Dunne RF, Loh KP, Mohile NA, Kesler SR, Mustian KM. Pilot trial testing the effects of exercise on chemotherapy-induced peripheral neurotoxicity (CIPN) and the interoceptive brain system. Research Square. PMID 38559210 DOI: 10.21203/rs.3.rs-4022351/v1 |
0.175 |
|
| 2020 |
Haroutounian S, Todorovic MS, Leinders M, Campagnolo M, Gewandter JS, Dworkin RH, Freeman R. Diagnostic criteria for idiopathic small fiber neuropathy: A systematic review. Muscle & Nerve. PMID 32989823 DOI: 10.1002/mus.27070 |
0.172 |
|
| 2015 |
Markman JD, Frazer ME, Rast SA, McDermott MP, Gewandter JS, Chowdhry AK, Czerniecka K, Pilcher WH, Simon LS, Dworkin RH. Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudication. Neurology. 84: 265-72. PMID 25503625 DOI: 10.1212/Wnl.0000000000001168 |
0.171 |
|
| 2015 |
Markman JD, Gewandter JS, Frazer ME, Murray NM, Rast SA, McDermott MP, Chowdhry AK, Tomkinson EJ, Pilcher WH, Walter KA, Dworkin RH. A Randomized, Double-blind, Placebo-Controlled Crossover Trial of Oxymorphone Hydrochloride and Propoxyphene/Acetaminophen Combination for the Treatment of Neurogenic Claudication Associated With Lumbar Spinal Stenosis. Spine. 40: 684-91. PMID 25705958 DOI: 10.1097/Brs.0000000000000837 |
0.163 |
|
| 2016 |
Gewandter JS, Burke L, Cavaletti G, Dworkin RH, Gibbons C, Gover TD, Herrmann DN, McArthur Mb JC, McDermott MP, Rappaport BA, Reeve BB, Russell JW, Smith AG, Smith SM, Turk DC, et al. Content validity of symptom-based measures for diabetic, chemotherapy, and HIV peripheral neuropathy. Muscle & Nerve. PMID 27447116 DOI: 10.1002/Mus.25264 |
0.158 |
|
| 2015 |
Gewandter JS, Dale W, Magnuson A, Pandya C, Heckler CE, Lemelman T, Roussel B, Ifthikhar R, Dolan J, Noyes K, Mohile SG. Associations between a patient-reported outcome (PRO) measure of sarcopenia and falls, functional status, and physical performance in older patients with cancer. Journal of Geriatric Oncology. 6: 433-41. PMID 26365897 DOI: 10.1016/J.Jgo.2015.07.007 |
0.126 |
|
| 2017 |
Ryan Wolf J, Heckler CE, Guido JJ, Peoples AR, Gewandter JS, Ling M, Vinciguerra VP, Anderson T, Evans L, Wade J, Pentland AP, Morrow GR. Oral curcumin for radiation dermatitis: a URCC NCORP study of 686 breast cancer patients. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 29192329 DOI: 10.1007/S00520-017-3957-4 |
0.1 |
|
| 2018 |
Kleckner IR, Kamen C, Gewandter JS, Mohile NA, Heckler CE, Culakova E, Fung C, Janelsins MC, Asare M, Lin PJ, Reddy PS, Giguere J, Berenberg J, Kesler SR, Mustian KM. Response to Crevenna and Ashbury, Vallance and Bolam, and Crevenna and Keilani regarding the effects of exercise on chemotherapy-induced peripheral neuropathy. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 30374766 DOI: 10.1007/S00520-018-4528-Z |
0.095 |
|
| 2020 |
Gewandter JS, McDermott MP. When should non-significant results influence clinical decisions?: Interpreting confidence intervals. Bjog : An International Journal of Obstetrics and Gynaecology. PMID 31910324 DOI: 10.1111/1471-0528.15548 |
0.091 |
|
| 2020 |
Freeman R, Gewandter JS, Faber CG, Gibbons C, Haroutounian S, Lauria G, Levine T, Malik RA, Singleton JR, Smith AG, Bell J, Dworkin RH, Feldman E, Herrmann DN, Hoke A, et al. Idiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria. Neurology. PMID 33055271 DOI: 10.1212/WNL.0000000000010988 |
0.078 |
|
| 2009 |
Gewandter JS, Staversky RJ, O'Reilly MA. Hyperoxia augments ER-stress-induced cell death independent of BiP loss. Free Radical Biology & Medicine. 47: 1742-52. PMID 19786088 DOI: 10.1016/j.freeradbiomed.2009.09.022 |
0.074 |
|
| 2024 |
Baker JR, Beach PA, Ranada SI, Patel A, Gewandter J, Tan CO, Freeman R, Raj SR. Cerebral Blood Flow Dynamics in Neurogenic Orthostatic Hypotension: A Systematic Review and Meta-Analysis. Hypertension (Dallas, Tex. : 1979). PMID 39569517 DOI: 10.1161/HYPERTENSIONAHA.124.23188 |
0.056 |
|
| 2005 |
Wassif CA, Krakowiak PA, Wright BS, Gewandter JS, Sterner AL, Javitt N, Yergey AL, Porter FD. Residual cholesterol synthesis and simvastatin induction of cholesterol synthesis in Smith-Lemli-Opitz syndrome fibroblasts. Molecular Genetics and Metabolism. 85: 96-107. PMID 15896653 DOI: 10.1016/j.ymgme.2004.12.009 |
0.051 |
|
| 2021 |
Besharat S, Grol-Prokopczyk H, Gao S, Feng C, Akwaa F, Gewandter JS. Peripheral edema: A common and persistent health problem for older Americans. Plos One. 16: e0260742. PMID 34914717 DOI: 10.1371/journal.pone.0260742 |
0.045 |
|
| 2017 |
Gewandter JS, Dworkin RH, Finnerup NB, Freeman R, Mohile NA. Reply. Pain. 158: 182-183. PMID 27984531 DOI: 10.1097/j.pain.0000000000000744 |
0.031 |
|
| 2011 |
Gewandter JS, Bambara RA, O'Reilly MA. The RNA surveillance protein SMG1 activates p53 in response to DNA double-strand breaks but not exogenously oxidized mRNA. Cell Cycle (Georgetown, Tex.). 10: 2561-7. PMID 21701263 DOI: 10.4161/Cc.10.15.16347 |
0.027 |
|
| 2007 |
Hom JR, Gewandter JS, Michael L, Sheu SS, Yoon Y. Thapsigargin induces biphasic fragmentation of mitochondria through calcium-mediated mitochondrial fission and apoptosis. Journal of Cellular Physiology. 212: 498-508. PMID 17443673 DOI: 10.1002/Jcp.21051 |
0.022 |
|
| 2014 |
Kalifa L, Gewandter JS, Staversky RJ, Sia EA, Brookes PS, O'Reilly MA. DNA double-strand breaks activate ATM independent of mitochondrial dysfunction in A549 cells. Free Radical Biology & Medicine. 75: 30-9. PMID 25048973 DOI: 10.1016/J.Freeradbiomed.2014.07.011 |
0.02 |
|
| Hide low-probability matches. |